MIAMI – The lack of progress in development of drugs to effectively treat posttraumatic stress disorder (PTSD) has become a "crisis" and has led to a significant shift in the US Department of Veterans ...
This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). A U.S. Food and Drug ...
This photo provided by the Center for Psychedelic Therapy Research shows a Yehuda Lab MDMA-assisted therapy treatment room at the James J. Peters Department of Veterans Affairs Medical Center in the ...
A panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder. The meeting is the ...
A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a ...
If you buy something using links in our stories, we may earn a commission. Learn more. A team of neurobiologists has identified the area of the brain responsible for spontaneously recalling traumatic ...
No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or ...
CHICAGO, Sept 5 (Reuters) - People with post-traumatic stress disorder appear to have lower levels of a specific kind of brain chemical known as serotonin 1B, and targeting this with drugs could lead ...
Could a marijuana-based medicine potentially prevent the symptoms of post-traumatic stress disorder (PTSD)? If the findings of a new study in rodents hold up, they may offer a new avenue for treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback